Melisron (MLSR)

Tel Aviv


	Symbol		Exchange		Currency
	MLSR		Tel Aviv		ILS	Delayed
	ILMLSR20=TA		Tel Aviv		ILS	Delayed

Currency in ILS

32,830

+830(+2.59%)

Closed08/12

Fair Value

Day's Range

31,520

32,950

52 wk Range

23,590

32,950

MLSR Income Statement

Featured here, the Income Statement (earnings report) for Melisron, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

1,590

1,117

1,508

1,762

1,837

Total Revenues Growth

-0.25%

-29.75%

+35%

+16.84%

+4.26%

Cost Of Revenues

380

305

350

408

437

Gross Profit

1,210

812

1,158

1,354

1,400

Gross Profit Growth

+0.08%

-32.89%

+42.61%

+16.93%

+3.4%

Gross Profit Margin %

76.1%

72.69%

76.79%

76.84%

76.21%

Other Operating Expenses, Total

117

92

88

138

192

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+27.17%	-21.37%	-4.35%	+56.82%	+39.13%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	94	82	91	119	118
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	23	10	-3	19	74

Operating Income

1,093

720

1,070

1,216

1,208

Operating Income Growth

-2.15%

-34.13%

+48.61%

+13.64%

-0.66%

EBIT Margin %

68.74%

64.46%

70.95%

69.01%

65.76%

Net Interest Expenses

-263

-175

-384

-603

-460

Net Interest Expenses Growth

+34.25%

+33.46%

-119.43%

-57.03%

+23.71%

Interest Expense, Total

-306

-203

-437

-636

-526

Interest And Investment Income

43

28

53

33

66

Other Non Operating Expenses, Total

-4

-

-13

-36

-10

EBT, Excl. Unusual Items

826

545

673

577

738

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

952

-777

1,327

1,224

624

EBT, Incl. Unusual Items

1,778

-247

2,000

1,801

1,362

EBT, Incl. Unusual Items Growth

+122.81%

-113.89%

+909.72%

-9.95%

-24.38%

EBT, Incl. Unusual Items Margin

111.82%

-22.11%

132.63%

102.21%

74.14%

Income Tax Expense

416

-4

459

359

310

Net Income to Company

1,362

-243

1,541

1,442

1,052

Minority Interest

-86

-7

-68

-51

-15

Net Income

1,276

-250

1,473

1,391

1,037

Net Income Growth

+118.12%

-119.59%

+689.2%

-5.57%

-25.45%

Net Income Margin %

80.25%

-22.38%

97.68%

78.94%

56.45%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

1,276

-250

1,473

1,391

1,037

Basic EPS - Continuing Operations

28.42

-5.27

31.04

29.3

21.83

Basic EPS - Continuing Operations Growth

+116.75%

-118.54%

+688.98%

-5.61%

-25.48%

Diluted EPS - Continuing Operations

28.4

-5.27

31.01

29.25

21.81

Diluted EPS - Continuing Operations Growth

+116.59%

-118.56%

+688.36%

-5.67%

-25.43%

Basic Weighted Average Shares Outstanding

44.9

47.44

47.46

47.48

47.5

Diluted Weighted Average Shares Outstanding

44.93

47.44

47.51

47.56

47.55

Dividend Per Share

5.27

-

-

9.27

5.05

Dividend Per Share Growth

-1.79%

-

-

-

-45.48%

EBITDA

1,096

724

1,077

1,237

1,271

EBITDA Growth

-2.14%

-33.94%

+48.76%

+14.86%

+2.75%

EBITDA Margin %

68.93%

64.82%

71.42%

70.2%

69.19%

EBIT